![]() |
|
|
Vol. 300, Issue 3, 729-735, March 2002
CarePoint Diagnostics, Inc., Eden Prairie, Minnesota (R.J.S.); and
Pfizer Global Research, Ann Arbor Laboratories, Ann Arbor, Michigan
(K.S.K.)
The role of inflammation in cardiovascular disease and especially in
thrombogenesis has become increasingly recognized as an important
component of the overall disease process. Plaque rupture promotes
activation of the inflammatory response and increased expression of
tissue factor (TF), which in turn acts as one of the major initiators
of extrinsic coagulation. It is becoming apparent that the expression
of TF on endothelial cells, underlying smooth muscle cells and
monocytes is regulated, in part, by proinflammatory cytokines including
tumor necrosis factor and IL-1. In addition to initiating
coagulation, interaction of TF with the adhesion molecule, P-selectin,
has been demonstrated to accelerate the rate and extent of fibrin
formation and deposition. P-selectin is expressed on activated
platelets and endothelium and serves as the receptor for the endogenous
ligand, P-selectin glycoprotein-1 (PSGL-1), expressed on various
leukocytic cell types. In addition to mediating transient interactions
between endothelial cells and leukocytes, P-selectin has been reported
to mediate adherence of platelets to monocytes and neutrophils via
specific interaction with PSGL-1. P-selectin is rapidly cleaved off the
surface of the platelet membrane and appears in the circulation as a
soluble form, which has been reported to be elevated in patients with acute coronary syndromes including unstable angina and non-Q-wave myocardial infarction. This review will focus on the role of cytokines in mediating TF expression and also explore the significance of the
relationship between P-selectin and tissue factor in thrombus generation. In addition, possible pharmacological mechanisms to interrupt this disease process will be discussed.
This article has been cited by other articles:
![]() |
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll Inflammation, endothelium, and coagulation in sepsis J. Leukoc. Biol., March 1, 2008; 83(3): 536 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bose, K. Leineweber, T. Konorza, A. Zahn, M. Brocker-Preuss, K. Mann, M. Haude, R. Erbel, and G. Heusch Release of TNF-{alpha} during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2295 - H2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Y. Wang, Y.-C. Wu, and C.-C. Wu Prevention of Platelet Glycoprotein IIb/IIIa Activation by 3,4-Methylenedioxy-beta-Nitrostyrene, A Novel Tyrosine Kinase Inhibitor Mol. Pharmacol., October 1, 2006; 70(4): 1380 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parolari, L. Mussoni, M. Frigerio, M. Naliato, F. Alamanni, G. L. Polvani, M. Agrifoglio, F. Veglia, E. Tremoli, P. Biglioli, et al. The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Freedman Molecular Regulation of Platelet-Dependent Thrombosis Circulation, October 25, 2005; 112(17): 2725 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui The role of inflammation in atherothrombosis: implications for clinical practice Vascular Medicine, February 1, 2005; 10(1): 45 - 53. [Abstract] [PDF] |
||||
![]() |
C. Decoene, G. Fayad, S. Al-Ruzzeh, T. Modine, F. Crepin, A. Pol, and H. Warembourg Right ventricular assist device thrombosis during biventricular heart assistance Perfusion, December 1, 2004; 19(6): 365 - 367. [Abstract] [PDF] |
||||
![]() |
M. Levi, T. van der Poll, and H. R. Buller Bidirectional Relation Between Inflammation and Coagulation Circulation, June 8, 2004; 109(22): 2698 - 2704. [Full Text] [PDF] |
||||
![]() |
P. K. Henke, A. Varga, S. De, C. B. Deatrick, J. Eliason, D. A. Arenberg, P. Sukheepod, P. Thanaporn, S. L. Kunkel, G. R. Upchurch Jr, et al. Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1130 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miceli, R. Atoui, R. Walker, T. Mahfouz, N. Mirza, J. Diaz, G. Tricot, B. Barlogie, and E. Anaissie Diagnosis of Deep Septic Thrombophlebitis in Cancer Patients by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Scanning: A Preliminary Report J. Clin. Oncol., May 15, 2004; 22(10): 1949 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miceli, R. Atoui, R. Thertulien, B. Barlogie, E. Anaissie, R. Walker, and L. Jones-Jackson Deep Septic Thrombophlebitis: An Unrecognized Cause of Relapsing Bacteremia in Patients With Cancer J. Clin. Oncol., April 15, 2004; 22(8): 1529 - 1531. [Full Text] |
||||
![]() |
M. Nishimura, T. Hashimoto, H. Kobayashi, T. Fukuda, K. Okino, N. Yamamoto, N. Iwamoto, N. Nakamura, T. Yoshikawa, and T. Ono The high incidence of left atrial appendage thrombosis in patients on maintenance haemodialysis Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2339 - 2347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J F Kinsel and M V Sitkovsky Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Yee, J. R. Harkema, P. E. Ganey, and R. A. Roth The Coagulation System Contributes to Synergistic Liver Injury from Exposure to Monocrotaline and Bacterial Lipopolysaccharide Toxicol. Sci., August 1, 2003; 74(2): 457 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Kohm, P. A. Carpentier, H. A. Anger, and S. D. Miller Cutting Edge: CD4+CD25+ Regulatory T Cells Suppress Antigen-Specific Autoreactive Immune Responses and Central Nervous System Inflammation During Active Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2002; 169(9): 4712 - 4716. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF] |
||||
![]() |
J. E. Freedman and J. Loscalzo Platelet-Monocyte Aggregates: Bridging Thrombosis and Inflammation Circulation, May 7, 2002; 105(18): 2130 - 2132. [Full Text] [PDF] |
||||